← Back to Conditions
Autosomal dominant beta2-microglobulinic amyloidosis
disorderSNOMED 722292000CUI C4302669
Overview
Autosomal dominant beta2-microglobulinic amyloidosis is a disorder.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
CKD
Frequent (30-79%)HP:0012622
Constrictive median neuropathy
Frequent (30-79%)HP:0012185
Renal amyloidosis
Frequent (30-79%)HP:0001917
Abnormal vascular morphology
Occasional (5-29%)HP:0025015
Abnormality of muscle morphology
Occasional (5-29%)HP:0011805
Amyloid cardiomyopathy
Occasional (5-29%)HP:0030843
Amyloidosis of peripheral nerves
Occasional (5-29%)HP:0100292
Autonomic dysregulation
Occasional (5-29%)HP:0012332
Cardiovascular calcification
Occasional (5-29%)HP:0011915
Cutaneous amyloidosis
Occasional (5-29%)HP:0012309
Death of digestive organ tissue due to poor blood supply
Occasional (5-29%)HP:0005244
Glossal abnormality
Occasional (5-29%)HP:0000157
Hepatic amyloidosis
Occasional (5-29%)HP:0012280
Hip arthralgia
Occasional (5-29%)HP:0003365
Intestinal perforation
Occasional (5-29%)HP:0031368
Knee pain
Occasional (5-29%)HP:0030839
Multiple bony cystic lesions
Occasional (5-29%)HP:0012065
Nerve damage causing decreased feeling and movement
Occasional (5-29%)HP:0007141
Pathologic fracture
Occasional (5-29%)HP:0002756
Reduced ejection fraction
Occasional (5-29%)HP:0012664
Salivary gland disease
Occasional (5-29%)HP:0010286
Shoulder pain
Occasional (5-29%)HP:0030834
Spinal cord compression
Occasional (5-29%)HP:0002176
Wrist pain
Occasional (5-29%)HP:0030836
Quick Facts
- SNOMED CT
- 722292000
- UMLS CUI
- C4302669
- Fully Specified Name
- Autosomal dominant beta2-microglobulinic amyloidosis (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 24
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.